Shuttle Pharmaceuticals Holdings (SHPH) Accounts Payables (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Accounts Payables history runs 6 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 99.55% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (up 99.55% YoY), while the FY2025 annual figure was $1.5 million, up 143.68% from the prior year.
• Accounts Payables was $1.8 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $1.5 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.8 million in Q1 2026 to a low of $88741.0 in Q2 2023.
• Historically, Accounts Payables has averaged $711207.4 across 5 years, with a median of $447474.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Accounts Payables slumped 85.91% in 2022, then jumped 649.14% in 2024.
• A 5-year view of Accounts Payables shows it stood at $116745.0 in 2022, then jumped by 142.29% to $282860.0 in 2023, then soared by 110.92% to $596600.0 in 2024, then surged by 143.68% to $1.5 million in 2025, then advanced by 23.11% to $1.8 million in 2026.
• The last three Accounts Payables figures came in at $1.8 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.